Chemical composition of the lipopolysaccharide from Edwardsiella tarda.

Abstract

may decrease the immunogenicity of the LPS preparation.

Construction and characterization of a live, attenuated esrB mutant of Edwardsiella tarda and its potential as a vaccine against the haemorrhagic septicaemia in turbot, Scophthamus maximus (L.)

“…Most of these vaccines are immunogenic, but no vaccine is commercially available at present. Although lipopolysaccharide (LPS) has been included in vaccine preparation, the protection efficiency is variable among the reported studies [7,10,11]. Recently, a 37-kDa outer membrane protein (OMP) of E. tarda has been studied in relation to inducing protective humoral and cell-mediated immunity [12e14].…”